ICD-10 Diagnosis Code C53.9

Malignant neoplasm of cervix uteri, unspecified

Diagnosis Code C53.9

ICD-10: C53.9
Short Description: Malignant neoplasm of cervix uteri, unspecified
Long Description: Malignant neoplasm of cervix uteri, unspecified
This is the 2019 version of the ICD-10-CM diagnosis code C53.9

Valid for Submission
The code C53.9 is valid for submission for HIPAA-covered transactions.

Code Classification
  • Neoplasms (C00–D48)
    • Malignant neoplasms of female genital organs (C51-C58)
      • Malignant neoplasm of cervix uteri (C53)

Information for Medical Professionals


Code Edits
The following edits are applicable to this code:
Diagnoses for females only - Diagnoses for females only.

Diagnostic Related Groups
The diagnosis code C53.9 is grouped in the following Diagnostic Related Group(s) (MS-DRG V35.0)

  • 736 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC
  • 737 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC
  • 738 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC
  • 739 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC
  • 740 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC
  • 741 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC

Convert to ICD-9
  • 180.9 - Mal neo cervix uteri NOS

Synonyms
  • Adenocarcinoma of cervix
  • Adenoma malignum
  • Adenosquamous carcinoma of cervix
  • Adenosquamous cell carcinoma
  • Carcinoma of cervix
  • Carcinoma of uterine cervix, invasive
  • FIGO CC stage I
  • FIGO CC stage IA1
  • FIGO CC stage IA2
  • FIGO CC stage Ib occ
  • FIGO CC stage IB1
  • FIGO CC stage IB2
  • FIGO CC stage II
  • FIGO CC stage IIA1
  • FIGO CC stage IIA2
  • FIGO CC stage IIB
  • FIGO CC stage III
  • FIGO CC stage IIIA
  • FIGO CC stage IIIB
  • FIGO CC stage IV
  • FIGO CC stage IVA
  • FIGO CC stage IVB
  • International Federation of Gynecology and Obstetrics cervical cancer stage Ia
  • International Federation of Gynecology and Obstetrics cervical cancer stage Ib
  • Invasive carcinoma of uterine cervix co-occurrent with human immunodeficiency virus infection
  • Local recurrence of malignant tumor of cervix
  • Malignant neoplasm of endocervical canal
  • Malignant neoplastic disease co-occurrent with human immunodeficiency virus infection
  • Malignant tumor involving an organ by direct extension from uterine cervix
  • Malignant tumor involving an organ by separate metastasis from uterine cervix
  • Malignant tumor involving bladder by direct extension from uterine cervix
  • Malignant tumor involving bladder by separate metastasis from uterine cervix
  • Malignant tumor involving left fallopian tube by direct extension from uterine cervix
  • Malignant tumor involving left fallopian tube by separate metastasis from uterine cervix
  • Malignant tumor involving left ovary by direct extension from uterine cervix
  • Malignant tumor involving left ovary by separate metastasis from uterine cervix
  • Malignant tumor involving rectum by direct extension from uterine cervix
  • Malignant tumor involving rectum by separate metastasis from uterine cervix
  • Malignant tumor involving right fallopian tube by direct extension from uterine cervix
  • Malignant tumor involving right fallopian tube by separate metastasis from uterine cervix
  • Malignant tumor involving right ovary by direct extension from uterine cervix
  • Malignant tumor involving right ovary by separate metastasis from uterine cervix
  • Malignant tumor involving uterine corpus by direct extension from uterine cervix
  • Malignant tumor involving uterine corpus by separate metastasis from uterine cervix
  • Malignant tumor involving vagina by direct extension from uterine cervix
  • Malignant tumor involving vagina by separate metastasis from uterine cervix
  • Malignant tumor involving vulva by direct extension from uterine cervix
  • Malignant tumor involving vulva by separate metastasis from uterine cervix
  • Malignant tumor of cervix
  • Metastasis from malignant tumor of cervix
  • pM1
  • Primary adenocarcinoma of cervix uteri
  • Primary malignant neoplasm of uterine cervix
  • pT1
  • pT1a
  • pT1a1
  • pT1a1 category
  • pT1a2
  • pT1a2 category
  • pT1b
  • pT1b1
  • pT1b1 category
  • pT1b2
  • pT1b2 category
  • pT2
  • pT2a
  • pT2b
  • pT3
  • pT3a
  • pT3b
  • pT4
  • Secondary malignant neoplasm of body of uterus
  • Secondary malignant neoplasm of left fallopian tube
  • Secondary malignant neoplasm of left ovary
  • Secondary malignant neoplasm of rectum
  • Secondary malignant neoplasm of right fallopian tube
  • Secondary malignant neoplasm of right ovary
  • Secondary malignant neoplasm of vagina
  • Secondary malignant neoplasm of vulva
  • Squamous cell carcinoma of cervix
  • T1 : Cervical carcinoma confined to uterus
  • T1a : Invasive carcinoma of uterine cervix diagnosed by microscopy only
  • T1a1 : Tumor of uterine cervix with stromal invasion < 3.0 mm in depth and horizontal spread < 7.0 mm
  • T1a2 : Tumor of uterine cervix with stromal invasion > 3.0 mm but < 5.0 mm in depth and horizontal spread < 7.0 mm
  • T1b : Tumor of uterine cervix with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2
  • T1b1 : Tumor of uterine cervix, clinically visible lesion < 4.0 mm in greatest dimension
  • T1b2 : Tumor of uterine cervix, clinically visible lesion > 4.0 mm in greatest dimension
  • T2 : Tumor of uterine cervix invades beyond the uterus but not to pelvic wall or to lower third of vagina
  • T2a : Tumor of uterine cervix, T2 without parametrial invasion
  • T2b : Tumor of uterine cervix, T2 with parametrial invasion
  • T3 : Tumor of uterine cervix extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or nonfunctioning kidney
  • T3a : Tumor of uterine cervix involves lower third of vagina, but not pelvic wall
  • T3b : Tumor of uterine cervix extends to pelvic wall and/or causes hydronephrosis or nonfunctioning kidney
  • T4 : Tumor of uterine cervix/vagina invades mucosa of bladder or rectum and/or extends beyond true pelvis

Table of Neoplasms

The code C53.9 is included in the table of neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate.

Where such descriptors are not present, the remainder of the Index should be consulted where guidance is given to the appropriate column for each morphological (histological) variety listed. However, the guidance in the Index can be overridden if one of the descriptors mentioned above is present.

The Tabular must be reviewed for the complete diagnosis code.

Neoplasm, neoplastic Malignant
Primary
Malignant
Secondary
CaInSitu Benign Uncertain
Behavior
Unspecified
Behavior
»cervix (cervical) (uteri) (uterus)
C53.9C79.82D06.9D26.0D39.0D49.59
»uterus, uteri, uterine
  »cervix
C53.9C79.82D06.9D26.0D39.0D49.59

Information for Patients


Cervical Cancer

The cervix is the lower part of the uterus, the place where a baby grows during pregnancy. Cervical cancer is caused by a virus called HPV. The virus spreads through sexual contact. Most women's bodies are able to fight HPV infection. But sometimes the virus leads to cancer. You're at higher risk if you smoke, have had many children, use birth control pills for a long time, or have HIV infection.

Cervical cancer may not cause any symptoms at first. Later, you may have pelvic pain or bleeding from the vagina. It usually takes several years for normal cells in the cervix to turn into cancer cells. Your health care provider can find abnormal cells by doing a Pap test to examine cells from the cervix. You may also have an HPV test. If your results are abnormal, you may need a biopsy or other tests. By getting regular screenings, you can find and treat any problems before they turn into cancer.

Treatment may include surgery, radiation therapy, chemotherapy, or a combination. The choice of treatment depends on the size of the tumor, whether the cancer has spread and whether you would like to become pregnant someday.

Vaccines can protect against several types of HPV, including some that can cause cancer.

NIH: National Cancer Institute

  • Cervical cancer (Medical Encyclopedia)
  • Cervical Cancer (Centers for Disease Control and Prevention)
  • Cervical cancer -- screening and prevention (Medical Encyclopedia)
  • Cervical dysplasia (Medical Encyclopedia)
  • Treatment Option Overview (Cervical Cancer) - NIH (National Cancer Institute)
  • Understanding Chemotherapy - NIH - Easy-to-Read (National Cancer Institute)
  • What to Know about Brachytherapy (A Type of Internal Radiation Therapy) - NIH - Easy-to-Read (National Cancer Institute)
  • What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)

[Read More]

ICD-10 Footnotes

General Equivalence Map Definitions
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
  • No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
  • Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.

Present on Admission
The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement.

Previous Code
C53.8
Next Code
C54